α2-巨球蛋白用于研究脂蛋白受体介导的血浆淀粉样蛋白-β 外周结合受损,这是阿尔茨海默′病前轻度认知障碍的早期生物标志物。它还用于控制补体激活的经典途径和 MBL 途径。通过与蛋白酶形成复合物来抑制所有种类的内切蛋白酶。当蛋白酶切割巨球蛋白“诱饵”序列时,巨球蛋白重新排列并捕获蛋白酶。
α2-Macroglobulin was used to study impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β which is an early biomarker for mild cognitive impairment preceding Alzheimer′s disease. It was also used in the control of the classical and the MBL pathway of complement activation.
Inhibits all classes of endoproteases by forming a complex with the protease. When the protease cleaves the macroglobulin 'bait' sequence, the macroglobulin rearranges and traps the protease.